NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs041180163

Registered date:29/03/2019

The Effect of Tranexamic Acid for EL2 after EVAR.

Basic Information

Recruitment status Complete
Health condition(s) or Problem(s) studiedAbdominal aortic aneurysm, iliac artery aneurysm
Date of first enrollment20/05/2017
Target sample size100
Countries of recruitment
Study typeInterventional
Intervention(s)Tranexamic acid group: tranexamic acid 250mg*3/day given on day1 to 30 after EVAR. Non Tranexamic acid group: Do not give any additional drugs.

Outcome(s)

Primary OutcomeIncidence of type2 endoleak
Secondary OutcomeChanges in the size of aneurysms after EVAR

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximum<= 100age old
GenderBoth
Include criteriaPatients who undergo first bifurcated stent graft treatment for abdominal aortic aneurysm and iliac artery aneurysm at Aichi Medical University Hospital.
Exclude criteriaPatents who cannot take internal medicine.

Related Information

Contact

Public contact
Name YUSUKE IMAEDA
Address 1-1 Yazako-karimata Nagakute City Aichi Aichi Japan 480-1195
Telephone +81-561-62-3311
E-mail yusuke_ima@aichi-med-u.ac.jp
Affiliation Aichi Medical University Hospital
Scientific contact
Name YUSUKE IMAEDA
Address 1-1 Yazako-karimata Nagakute City Aichi Aichi Japan 480-1195
Telephone +81-561-62-3311
E-mail yusuke_ima@aichi-med-u.ac.jp
Affiliation Aichi Medical University Hospital